Panagora Asset Management’s Health Catalyst HCAT Stock Holding History

Panagora Asset Management’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-36,670	Closed	-$428K	–	1349
2023 Q1	$428K	Buy	36,670 +1,079	+3%	+$13.8K	﹤0.01%	1166
2022 Q4	$378K	Sell	35,591 -8,551	-19%	-$82.6K	﹤0.01%	1226
2022 Q3	$428K	Buy	44,142 +16,288	+58%	+$216K	﹤0.01%	1184
2022 Q2	$404K	Buy	+27,854	New	+$475K	﹤0.01%	1225
2021 Q3	–	Sell	-154	Closed	-$9K	–	2002
2021 Q2	$9K	Buy	+154	New	+$8.2K	﹤0.01%	2296
2020 Q4	–	Sell	-2,105	Closed	-$77K	–	2852
2020 Q3	$77K	Hold	2,105	–	–	﹤0.01%	1912
2020 Q2	$61K	Hold	2,105	–	–	﹤0.01%	1924
2020 Q1	$55K	Buy	+2,105	New	+$64.3K	﹤0.01%	1861

Other funds holding HCAT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Daventry Group New York $133M AUM 32.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Panagora Asset Management's HCAT Position: Q2 2023 in Review

Panagora Asset Management sold out of Health Catalyst (HCAT) in Q2 2023, closing a stake of 36,670 shares — an estimated $428K sold.

Panagora Asset Management first reported a position in HCAT in Q1 2020 and held it in 8 quarters. The position peaked at $428K in Q3 2022. 154 funds tracked by Wall St. Rank hold HCAT as of Q2 2023.

Panagora Asset Management reported no remaining Health Catalyst position as of Q2 2023 after selling out during the quarter.
Panagora Asset Management sold 36,670 Health Catalyst shares in Q2 2023, an estimated $428K.
Panagora Asset Management first reported a position in Health Catalyst in Q1 2020 and held it in 8 quarters.
Panagora Asset Management's Health Catalyst position peaked at $428K in Q3 2022.
154 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2023.

Based on Panagora Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.